Recent data have shown that SARS-CoV-2 has developed strategies to counteract IFNs, and SARS-CoV-2 efficiently antagonizes IFN effects that fail to suppress viral replication at the initial stage of infection [5]. The gene discussed is IFNA1; the disease is infection.